Abstract: Three-dimensional ultrasound is an imaging technique that is being introduced into clinical practice in several medical specialties. Although this technique is unlikely to replace the two-dimensional ultrasound, its role as a diagnostic tool is being explored. In fact, in the field of gynecology there has been a steady increase in the number of papers published in the last few years. These applications include: imaging the uterus, uterine cavity, adnexa, and pelvic floor as well as reproductive medicine, such as the prediction of IVF success or ovarian hyperstimulation syndrome. The aim of this paper is to review the current status of threedimensional ultrasound in clinical practice in gynecology.
Introduction
Conventional two-dimensional ultrasound (2D-US) is widely used in gynecological practice and it may be considered as an essential imaging technique for diagnosing uterine and adnexal pathology. 1 In the last decade, three-dimensional ultrasound (3D-US) has become available for clinical use. Initially focused on obstetrical imaging, its role in gynecology is currently being explored.
Although this technique has been applied in almost every field in gynecology such as pelvic floor, [2] [3] [4] reproductive medicine, [5] [6] [7] and uterine and adnexal pathology, 8, 9 we shall focus on those issues more frequently seen in a gynecological clinic: uterine and adnexal pathology.
We performed a comprehensive computerized search to identify all articles published in English literature related to 3D-US in uterine and adnexal pathology. The search was performed in the MEDLINE database from January 1996 to November 2011 using different combinations of the following keywords: three-dimensional, ultrasound, uterine Müllerian anomalies, uterine congenital anomalies, ovarian tumor, adnexal masses, adenomyosis, myoma, uterine bleeding, sonohysterography, ovarian cancer, and endometrial cancer.
One author (JLA) read all abstracts of articles identified through the computer search. To be included for complete assessment, the articles had to provide the following information: (1) aim, (2) study design, (3) type of data collection, (4) sampling method, (5) 3D-US methodology used.
Case reports, review articles, and Letters to Editor as well as non-English language articles were excluded.
In studies comparing 3D-US and 2D-US, two-by-two tables for calculating sensitivity and specificity for each method were constructed whenever possible from raw data reported in those studies.
Cross-references of all selected articles were checked for other articles meeting inclusion criteria.
Technical notes
A detailed description of technical issues regarding 3D-US is beyond the scope of this article. There are several published papers that address this question and reading is advised. [10] [11] [12] However, we shall briefly describe some technical considerations.
Three-dimensional ultrasound requires the use of dedicated 3D transducers. These are available from most high-brand ultrasound device manufacturers. When these probes are activated, the transducer elements automatically sweep through the region of interest (ROI) selected by the operator (the so-called "volume box") while the probe is held stationary. The operator can select a constant speed of sweep through the ROI using machine settings. Lower speeds result in higher resolution, and a larger volume box leads to longer acquisition time. Once the 3D volume is acquired it can be digitally stored and transferred via DICOM (Nema, Rosslyn, VA) to a personal computer for further assessment with dedicated software.
The 3D volume can be manipulated in several ways. Probably the most used and useful display is multiplanar display, which simultaneously shows three orthogonal planes (axial, longitudinal, and coronal) allowing navigation through these three planes. The coronal plane is almost impossible to obtain in conventional vaginal ultrasound and difficult to obtain in abdominal ultrasound but easy to reconstruct using 3D ultrasound. This is a significant benefit, at least theoretically, compared to conventional ultrasound. It is possible to switch to any desired plane and an accurate spatial orientation is virtually always possible (Figure 1 ).
Other displays for 3D-US are: 1. Tomographic ultrasound imaging that presents images like magnetic resonance imaging does ( Figure 2 ). 2. Surface rendering that shows surfaces (Figure 3 ). 3. "Niche" mode that shows an "in-block" imaging of the ROI allowing a 3D spatial orientation (Figure 4 ). 4. "Omni-view" mode that shows one perpendicular plane over the other making the imaging simpler ( Figure 5 ). 5. "Inversion" mode that shows as "opaque" what is a fluidfilled structure giving a more precise idea of the shape of the cystic cavity ( Figure 6 ). Another important ability of 3D-US is volume calculation even in irregularly shaped structures using the Virtual Organ Computer-aided Analysis (VOCAL TM ; GE Healthcare, Wein, Austria) 13 and Automated Volume calculation (SonoAVC; General Electric Company, Schenectady, NY) specifically designed for automatic volume estimation of cystic structures ( Figure 7) . This method has been demonstrated to be more accurate than 2D uterine and ovarian volume estimation. [14] [15] [16] [17] [18] [19] The addition of power Doppler to three-dimensional ultrasound allows the assessment of organ/tissue vascularity. By using 3D power Doppler angiography (3D-PDA) it is possible to reconstruct the vascular tree within a given ROI. This reconstructed vascular tree can be subjectively analyzed. 20 On the other hand, using VOCAL software three-dimensional power Doppler-derived indices can be calculated from a given ROI. 21 These indices were named Vascularization Index (VI), Flow Index (FI), and Vascularization-Flow Index (VFI). These indices are based and related to the total and relative amount of power Doppler information within the ROI. The VI is expressed as a percentage and measures the ratio between the number of color voxels and total number of voxels within the ROI. The FI is unitless and is the average color value of all color voxels. VI is thought to reflect the amount of vessels within the ROI, whereas FI is thought to reflect the intensity of flow within those vessels at the time of 3D sweep. VFI is just a mathematical relationship between VI and FI and it is thought to represent both blood flow and vascularization. Actually, it is not well known what these indices are really measuring. 22 According to in vitro and in vivo studies, VI seems to be related to the number of vessels and flow, whereas there are doubts about the meaning of FI.
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Figure 4 Three-dimensional ultrasound from an ovarian cyst seen depicting the "niche" mode. The cyst exhibits three papillary projections. A vessel is also seen within the cyst wall. Niche mode shows this vessel is not entering the papillary projection. Furthermore, these indices are significantly affected by machine settings, such as gain and pulse repetition frequency as well as tissue attenuation. [26] [27] [28] For these reasons, there is concern about their use in clinical practice. 29, 30 Finally, analysis can be done off-line and not in realtime, which avoids the need for immediate reporting. This technique has been shown to improve workflow in an ultrasound laboratory 31 and may also be useful for teaching and second opinion.
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Three-dimensional ultrasound in uterine pathology Uterine Müllerian anomalies Although conventional 2D US has shown a good performance for discriminating different types of uterine anomalies, 33 it is highly dependent on the expertise of the examiner, 34 and it is limited by the difficulty to obtain the coronal plane of the uterus in most cases. Several studies have demonstrated the advantages of 3D-US (Table 1) .
Jurkovic and colleagues compared 2D-US, 3D-US, and hysterosalpingography (HSG) for diagnosing congenital uterine malformations. They used HSG as gold standard and found that 3D-US was more accurate than 2D-US for diagnosing arcuate uterus and had a higher positive predictive value for diagnosing major anomalies, especially for differentiating subseptated and bicornuate uteri. 35 Raga and coworkers evaluated the diagnostic accuracy of 3D-US for diagnosing congenital uterine anomalies using laparoscopy and HSG as the gold standard. They found that 3D-US correctly classified 92% of all anomalies. 36 Wu and colleagues performed a similar study, but using laparoscopy and hysteroscopy as the gold standard. Three-dimensional ultrasound detected 92% of septated uteri and 100% bicornuate uteri. 37 More recent studies have confirmed these results and definitions for different anomalies have been proposed. [38] [39] [40] [41] [42] Salim and coworkers have shown that 3D-US is a reproducible method for diagnosing congenital uterine anomalies. 43 Bermejo et al have demonstrated that 3D-US is as accurate as magnetic resonance imaging. 44 For these reasons 3D-US is currently considered as the first step imaging technique for diagnosing uterine congenital anomalies 45 ( Figures 8-10 ). The potential clinical value of using 3D-US for diagnosing congenital uterine anomalies has been shown in two studies, which both found that screening uterine malformations by means of 3D-US may improve reproductive outcomes.
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Intracavitary uterine lesions
Uterine abnormal bleeding is a common complaint in gynecologic clinics. Two-dimensional saline infusion sonohysterography (2D-SIS) has been demonstrated to be a very useful tool for diagnosing intracavitary abnormalities. [48] [49] [50] Several studies have tried to answer the question whether three-dimensional sonohysterography (3D-SIS) would add useful information to 2D-SIS.
La Torre and coworkers found that 3D-SIS was more specific (100%) than 2D-SIS (94%) for diagnosing endometrial polyps in a series of only 16 women suspected of having such a pathology in conventional 2D transvaginal ultrasound. 51 Lev-Toaff and colleagues found that 3D-SIS added valuable information to 2D-SIS in 69% of their cases and in 92% of the cases when compared to HSG. 52 However, their sample size was small (only 13 patients underwent both 2D-SIS and 3D-SIS). The advantages they found were: confirming suggestive findings on 2D-SIS or HSG and establishing the location, number, and attachments of endometrial polyps, submucous fibroids, and adhesions. Similar conclusions were drawn by Ghate et al in a series of 42 women. They found that 3D-SIS added valuable information for assessing the uterine fundus. 53 However, in these two studies, specificity for each method could not be calculated because for women with normal findings on ultrasound, no further tests were performed. Sylvestre et al evaluated the diagnostic accuracy of 3D-SIS for diagnosing intracavitary lesions in 209 infertile women. They found that when compared to hysteroscopy, 3D-SIS had a sensitivity of 100% and a positive predictive value of 92%. However, these figures were not different than those for 2D-SIS (98% and 95%, respectively). 54 As in the previously mentioned papers, specificity for each method could not be calculated because of lack of gold standard test information in women with normal findings.
De Kroon and coworkers compared 3D-SIS and 2D-SIS in 49 patients suspected of having intracavitary abnormalities. They concluded that 2D-SIS and 3D-SIS had similar performance (Sensitivity: 95% for both techniques. Specificity: 100% for 3D-SIS versus 88% for 2D-SIS), but 3D-SIS added "relevant clinical" information in 7% of their patients. 55 Makris et al evaluated 124 women with suspected intracavitary lesions by 3D-SIS 56 using hysteroscopy and endometrial biopsy as the gold standard. The technique failed in three women due to cervical stenosis. They found that sensitivity and specificity for this technique were 91.9% and 98.8%, respectively.
Terry et al compared 3D-SIS with 2D-SIS using hysteroscopy as the gold standard as well. 3D-SIS was more specific than 2D-SIS (75% versus 62%) with similar sensitivity (93% versus 99%), but differences did not reach statistical significance. 57 Opolskiene and colleagues did not find differences between 2D-SIS and 3D-SIS for predicting malignancy in women presenting with postmenopausal bleeding. 58 In summary, 3D-SIS seems not to be superior to 2D-SIS for diagnosing intracavitary lesions but helps to reinforce diagnosis and may add some information in some cases ( Figure 11) .
One interesting issue is the assessment of submucous myomas. Salim et al demonstrated that 3D-SIS had a similar accuracy to hysteroscopy for classifying submucous fibroids. They found that agreement between both techniques was high. 59 Furthermore, 3D-SIS is reproducible among different observers for such a classification. 60 A recent study has shown that 3D-SIS may be useful for predicting complete hysteroscopic resection of submucous myomas. 61 
Adenomyosis
Adenomyosis is a relatively frequent disease that is difficult to diagnose. 62 Transvaginal ultrasound has shown an acceptable diagnostic performance comparable to magnetic resonance imaging. Only one study has assessed the role of 3D-US for diagnosing adenomyosis. Exacoustos et al evaluated 72 premenopausal women scheduled for a hysterectomy for their benign condition. 63 Thirty-two of them had histologically proven uterine adenomyosis. They found that the uterine coronal plane was useful for assessing the "junctional zone," the uterine compartment at the endomyometrial interface that is thought to be involved in the pathogenesis of adenomyosis. The junctional zone can be visualized as a hypoechoic area surrounding the endometrium and can be measured as the distance from the basal endometrium to the internal layer of the outer myometrium ( Figure 12 ). They found that 3D-US had a better sensitivity than 2D-US (91% versus 75%) with similar specificity (88% versus 90%) for diagnosing adenomyosis.
More recently, Naftalin et al have demonstrated that assessment visualization and measurement of the uterine junctional zone by 3D-US had good intra-and inter-observer reproducibility. 64 
Endometrial pathology
Endometrial thickness measurement is a well-established method for identifying women with higher risk for endometrial cancer in postmenopausal bleeding. 65 However, although sensitive enough, endometrial thickness is non-specific. 66 Three-dimensional ultrasound allows the assessment of endometrial volume ( Figure 13 ). This is clinically attractive since theoretically endometrial volume may reflect more accurately the amount of endometrial tissue. 67 In fact, endometrial volume estimation has shown to be reproducible in tumoral endometria. 68 Several studies have evaluated the role of 3D-US endometrial volume assessment as compared to endometrial thickness measurement for predicting endometrial cancer in women with postmenopausal bleeding (Table 2) .
Two studies show that endometrial volume is more sensitive than endometrial thickness for diagnosing endometrial cancer. Gruboeck et al analyzed the diagnostic value of endometrial volume for diagnosing endometrial cancer in a series of 97 patients with postmenopausal bleeding. 69 They reported that an endometrial volume $13.0 mL would detect all endometrial cancers with a false-positive rate of 1.2%. They included all patients without regarding endometrial thickness but only eleven cases had endometrial cancer. Mansour et al reached similar conclusions in a series of 170 women with postmenopausal bleeding. 70 However, these authors reported that the best cut-off for endometrial volume Figure 13 Endometrial volume estimation by vOCAL method using threedimensional ultrasound.
Figure 11
Three-dimensional saline infusion sonohysterography. The internal uterine cavity surface is shown. Three lesions can be seen (arrows A, B, and C). Combination with multiplanar display allows spatial orientation. In fact, lesion C is not shown in 2D planes but it is seen on surface rendering.
Figure 12
Three-dimensional ultrasound from a uterus that shows the junctional zone in coronal plane (arrows). It can be measured and its integrity may also be assessed. On the other hand, Yaman et al found that endometrial volume was more specific than endometrial thickness in a series of 213 women, 42 with endometrial cancer. 71 In this study, the best cut-off for endometrial volume was 2.7 mL (100% sensitivity and 69% specificity). Other studies have shown similar findings, but all of them offered different cut-off values for endometrial volume. [72] [73] [74] In contrast, Opolskiene et al did not find differences between endometrial volume and thickness in terms of sensitivity and specificity for diagnosing endometrial cancer in women with postmenopausal bleeding and an endometrial thickness .4.5 mm. 75 One recent retrospective study has assessed the endometrial/uterine corporeal volume ratio (EV/UCV) in a series of 160 women with postmenopausal bleeding. 76 This study concluded that an EV/UCV ratio .0.017 was more accurate in the prediction of endometrial malignancy.
In summary, current information regarding the role of endometrial volume for predicting endometrial cancer in postmenopausal women seems to be controversial and further research with better designed studies and larger series is needed.
Regarding the role of 3D-PDA in this clinical setting, five studies have been published (Table 3) .
Odeh et al reported that all three 3D-PD indices were significantly higher in women with endometrial cancer as compared with those with benign pathology. 72 However, they did not compare with conventional 2D-PD and the specificity reported was low. Mercé et al found that 3D-PD indices were significantly higher in women with endometrial cancer as compared with those with endometrial hyperplasia, 73 but the study was retrospective, the series was small, and it did not include other endometrial pathology. Alcázar et al also found that 3D-PD indices were significantly higher in women with endometrial cancer as compared with those with benign pathology, 74 but this study included only women with endometrial thickness above 5 mm and did not compare 3D results with conventional 2D color Doppler.
Opolskiene et al reported data in a series of women with post menopausal bleeding and endometrial thickness .4.5 mm. 75 They concluded that, although 3D-PD Notes: *Endometrial hyperplasia and cancer included in the same "pathologic" group; † retrospective study assessing only women with endometrial hyperplasia and cancer; ‡ prospective study including only women with thickened endometrium. Abbreviations: EC, endometrial cancer; ET, endometrial thickness; EV, endometrial volume; sens, sensitivity; spec, specificity; NA, not available; AUC, area under the curve for ROC curves. indices were significantly higher in women with endometrial cancer as compared with those with benign pathology, this technique adds little information to endometrial thickness or volume. Lieng et al analyzed a small series of women with endometrial polyps (n = 17) and endometrial cancer (n = 17) comparing 3D-PD indices within the lesions before and after contrast-enhanced examination. 77 They did not find differences between the groups in the 3D-PD indices.
Only two studies have evaluated the use of 3D-US in women known as having an endometrial cancer.
Alcázar et al described and analyzed the diagnostic performance of a new method for assessing myometrial infiltration preoperatively based on 3D-ultrasound. 78 This new approach was based on a three-dimensional virtual navigation through the uterus for detecting the deepest point of myometrial infiltration in a series of 96 women with endometrial cancer. The most interesting finding from this study was the negative predictive value (100%) for deep infiltration reported using this approach. However, the false-positive rate reported was 39%.
Galván et al assessed the correlation between intratumoral 3D-PDA indices and several histological tumor characteristics in a series of 99 women with endometrial cancer. 79 In their analysis, endometrial volume and vascularization index were independently associated with myometrial infiltration and tumor stage, vascularization index was independently associated with tumor grade, and endometrial volume correlated with lymph node metastases. However, these data can be considered as preliminary and need to be validated.
Three-dimensional ultrasound in adnexal pathology
Several studies have been published aiming to determine whether morphological 3D-US is better than conventional 2D-US for diagnosing ovarian cancer in women with adnexal masses (Table 4) .
Bonilla-Musoles et al reported a series of 76 women in whom the same examiner performed both 3D-US and 2D-US. 80 They found that 3D-US is able to show internal papillary projections missed when using conventional 2D-US in 7% of the cases. 3D-US was more sensitive than 2D-US (100% versus 80%), with similar specificity.
Hata et al reported a series of 20 women in whom the different examiners performed both 3D-US and 2D-US. 81 They found that 3D-US was more specific than 2D-US (92.3% versus 38.4%) with similar sensitivity.
Alcázar et al reported a series of 41 women diagnosed as having complex adnexal masses on 2D-US. Two different examiners performed 3D-US and 2D-US. 82 In this study 3D-US was not better than 2D-US for predicting ovarian malignancy, but it helped to reinforce the examiner's diagnostic impression. This same group reported a second series with similar results to the previous one. 83 Laban et al in a series of 50 masses found that 3D-US had a higher sensitivity and specificity than 2D-US. 84 Some studies have assessed the role of 3D-PDA for discriminating benign from malignant adnexal masses.
Cohen et al aimed to determine if 3D-PD could improve the specificity of 2D-US morphological ultrasound in a series of 71 complex adnexal masses on 2D morphologic transvaginal ultrasound. 85 They did not use 2D conventional color Doppler or 2D power Doppler. In their approach, they combined 2D and 3D morphological features with 3D-PDA evaluation of blood flow tumor location, considering a tumor as malignant in the presence of complex morphological pattern and central (in papillary projections and/or septations) blood flow location. They concluded that the addition of 3D-PDA improved the specificity of 2D morphologic transvaginal ultrasound (75% versus 54%), with similar sensitivity. These results are not surprising and can be also achieved by using a simpler technique such as 2D power Doppler. [86] [87] [88] Three-dimensional power Doppler reconstruction of the tumoral vascular tree allows the assessment of microaneurysms, arteriovenous shunts, abnormal vessels branching, tortuosity, and vessel caliber changes, all of them characteristics of malignant tumors. 89 The first group to evaluate the vascular tree for predicting ovarian malignancy in adnexal masses was the group of Kurjak et al. [90] [91] [92] Although the authors "concluded" that 3D-PD was better than 2D-PD, no statistical analysis was reported supporting such a conclusion.
Several subsequent studies, all of them using similar criteria for malignancy suspicion, reported similar findings: 3D-PD vascular tree assessment adds little to conventional ultrasound. 84, [93] [94] [95] [96] Furthermore, this approach is only moderately reproducible. 93, 94 These studies are summarized in Table 5 .
The use of 3D-PDA derived indices for discriminating benign from malignant adnexal masses was first proposed by Alcázar et al. 97 In their report they proposed the assessment of 3D-PDA indices within the most suspicious vascularized area from the tumor in vascularized solid or cystic-solid masses, which are the most difficult to determine by conventional 2D-US and power Doppler. In a series of 69 vascularized solid and cystic-solid masses they found that all 3D-PDA indices were significantly higher in ovarian cancer as compared with benign tumors. This group demonstrated that this approach is reproducible. 98 Testa et al reported similar findings using different software in a series of 24 women with solid ovarian masses. 99 Geomini et al reported data from a series of 181 women with adnexal masses. 100 This study included any kind of mass diagnosed at transvaginal ultrasound and performed the vascular assessment from the whole tumor. They found that FI, but not VI and VFI, was significantly higher in malignant masses.
Jokubkiene et al proposed a modified approach based on the use of a virtual 5-cc spherical sampling from the most vascularized area from the tumor. They also found that 3D-PDA vascular indices were higher in ovarian cancer as compared with benign tumors, 101 but they concluded that this information was of little value as compared with gray-scale analysis performed by an experienced examiner. However, this study included any type of mass and not only those difficult to classify, which could be a source of bias. 102 Kudla et al proposed using a 1-cc spherical sampling and also found that 3D-PDA indices were significantly higher in malignant tumors. 103 Only one study has not shown differences in 3D-PD indices between benign and malignant ovarian tumors. 104 However, the series was too small (only 17 cases).
Alcázar and Prka compared manual and spherical sampling and concluded that both methods are comparable and that spherical sampling is faster to perform. However, 5-cc 
Notes:
† Criteria for malignancy suspicion: scoring system combining morphology and 3D-PD features; ‡ criteria for malignancy suspicion: logistic model combining morphology and 3D-PD features; § criteria for malignancy suspicion: only 3D-PD features; *only "complex" masses included in the study. Abbreviations: OC, ovarian cancer; 2D, two dimensional ultrasound; 3D-PD, three dimensional power Doppler; NS, statistically non-significant; NA, not available. spherical sampling cannot be used in about 20% of tumors, usually because of the small size of some lesions. 105 Several studies have shown that whatever the approach used, manual or spherical sampling, reproducibility is high between observers. 101, 103, 105, 106 Two prospective studies have shown that 3D-PDA may significantly decrease the false-positive rate of malignancy in vascularized solid and cystic-solid adnexal masses without decreasing significantly sensitivity. 107, 108 The results of these studies are summarized in Table 6 .
In summary, the use of 3D-PDA in adnexal masses seems to be encouraging. However, this technique is significantly affected by some factors such as machine settings and attenuation and needs to be standardized. 109 For this reason, its use cannot be introduced to general practice.
Some authors have proposed new approaches to overcome this problem, [110] [111] [112] however, further prospective studies are needed.
Summary
Three-dimensional ultrasound is an imaging technique that allows unique ways for assessing uterine and adnexal pathology. From the clinical point of view it can be considered that, in general, there is a lack of robust data to support routine use of 3D-US. However, some authors consider this technique as the standard imaging technique for diagnosing uterine Müllerian anomalies. It seems to provide additional information for identifying intracavitary uterine lesions.
Its role in endometrial and adnexal pathology is controversial and further research is needed in these areas.
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